Answers are grounded in this paper and cite their sources.
Analysis shows R&D investments reduce short-term profit but enhance long-term market value in firms, indicating critical trade-offs.
This study explores the effect of research and development (R&D) investments on the financial performance of firms listed on the Pakistan Stock Exchange (PSX) from 2005 to 2021. Using a dynamic panel dataset of 51 publicly traded companies from different industries, the research employs a two-step System Generalized Method of Moments (System GMM) estimation to tackle potential endogeneity, firm-specific differences, and dynamic feedback effects. Financial performance is measured through both accounting indicators (Return on Assets, ROA) and market indicators (Tobin’s Q). The empirical findings show a dual pattern: R&D intensity negatively affects short-term profitability (measured by ROA), likely because of immediate costs and how R&D expenses are accounted for. At the same time, R&D intensity has a positive and significant impact on long-term market value (as indicated by Tobin’s Q), which reflects investor optimism and the strategic importance of innovation. These results highlight the trade-off faced by R&D-active firms between short-term operational efficiency and long-term growth. The study also finds that firm size enhances the positive effects of R&D, while financial leverage decreases both operational and market performance. The findings add to academic literature (e.g., Alam et al., 2020; Khan et al., 2019; Shahbaz et al., 2021) and provide practical insights for corporate managers, investors, and policymakers seeking to align innovation strategies with sustainable financial success.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: